Are these 2 impressive ASX shares buys for 2022?

ELMO Software is one of the potential options for 2022.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The next year is almost here. There are some impressive ASX shares to consider for 2022 which experts have rated as buys.

Businesses which are growing quickly have the ability to achieve attractive compound growth over a number of years.

a woman stares ahead with a serious expression on her face while half of her face is covered by computer coding, indicative of artificial intelligence and machine learning technology.

Image source: Getty Images

Bubs Australia Ltd (ASX: BUB)

Bubs is a leading goat milk infant formula business, but the Bubs share price has dropped by 24% this year.

The business is rated as a buy by the broker Citi, with a price target of $0.58. That suggests a potential rise of the share price of just over 25% in the next year, if the broker is right.

Citi notes the recovery that Bubs is seeing, particularly when it comes to the daigou channel. The broker also thinks that the ASX share can also expand its addressable market.

Bubs gave investors an insight into potential performance in 2022 with its FY22 first quarter update. Total gross revenue nearly doubled to $18.5 million, whilst Bubs infant formula daigou sales increased 648% year on year.

The ASX share is also making progress internationally. For the first three months of FY22, international (excluding China) gross revenue increased 489% year on year, contributing 24% of quarterly sales. Export sales of Bubs infant formula to markets outside of China grew 154%.

Bubs has signalled its expanding global strategy by establishing entities in New Zealand, China and the USA.

Looking at the product categories, the infant nutrition portfolio – which has higher margins than the adult goat dairy portfolio – saw growth of 89%. The infant formula gross revenue grew 124% year on year and 64% quarter on quarter.

Bubs management say that they are confident on its vision to take Bubs to a global stage.

ELMO Software Ltd (ASX: ELO)

ELMO Software is a leading HR and payroll tech company. It has a substantial presence in both Australia and the UK.

It's currently rated as a buy by the broker Morgan Stanley with a price target of $7.80. This would be a rise of more than 50%, if the broker's prediction ends up being right.

ELMO Software is steadily adding more modules for its small and medium clients to utilise. This can increase revenue made from the client, and make the ELMO software even more valuable to the client (and make them more 'sticky').

The broker thinks the ASX share can benefit from a number of tailwinds, such as more companies utilising digital tools and software.

In the first three months of FY22, revenue increased 52% to $20.7 million and annualised recurring revenue (ARR) surged 61% to $88.5 million. Cash receipts went up 78% to $27.7 million whilst the business had $75.7 million of cash on hand. The company becoming cashflow neutral/positive could help investor thoughts on the business, according to the broker.

Extending ELMO's module suite, it recently launched 'Experiences' for improve employee engagement and 'COVIDsecure' for things like recording, monitoring and reporting COVID vaccination and test status.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Elmo Software. The Motley Fool Australia owns and has recommended Elmo Software. The Motley Fool Australia has recommended BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A graphic image of a pile of gold coins balanced precariously with a house on top with smoke coming out of the chimney and a human figure with hands up as if to shield himself from the prospect of the house falling.
Broker Notes

This debt collector could surge 47% on negative gearing changes, Shaw and Partners says

A weaker housing market could be a boon for this company.

Read more »

Three young nerds dressed in suits with thinking caps and lightbulbs
Broker Notes

Brokers name 3 ASX shares to buy right now

Let's find out which shares top brokers are feeling bullish about this week.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

4 ASX shares Macquarie says could return more than 40%

The broker has made some bold predictions.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

A businessman hugs his computer and smiles.
Broker Notes

Why this ASX stock is a 'compelling value play'

Value investors might want to check out this share that Bell Potter is bullish on.

Read more »

Man holding a calculator with Australian dollar notes, symbolising dividends.
Broker Notes

Should I buy Rio Tinto shares for passive income?

A leading analyst provides his outlook for Rio Tinto shares and dividends.

Read more »

Woman with her fingers crossed and eyes shut.
Broker Notes

4 ASX shares upgraded by brokers this week

Brokers have new confidence in TPG Telecom, Deep Yellow, and other stocks this week.

Read more »

Three adorable children sit side by side at a table wearing upturned colanders on their heads fixed with shining light bulbs as they smile at the camera.
Broker Notes

Buy, hold, sell: Nick Scali, Nyrada, Wesfarmers shares

Experts reveal their ratings on three ASX shares in the retail and biotech segments. 

Read more »